A-P Meert

1.7k total citations
17 papers, 1.3k citations indexed

About

A-P Meert is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, A-P Meert has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in A-P Meert's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). A-P Meert is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (3 papers). A-P Meert collaborates with scholars based in Belgium, France and Luxembourg. A-P Meert's co-authors include Sculier Jp, J.J. Lafitte, Céline Mascaux, Thierry Berghmans, Bradley C. Martin, Philippe Lothaire, J‐M Verdebout, M Paesmans, P. Delmotte and M. Dusart and has published in prestigious journals such as British Journal of Cancer, European Respiratory Journal and Monaldi Archives for Chest Disease.

In The Last Decade

A-P Meert

14 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A-P Meert Belgium	7	799	732	548	266	118	17	1.3k
Takuro Kometani Japan	16	600 0.8×	624 0.9×	555 1.0×	178 0.7×	75 0.6×	43	1.2k
V. A. Miller United States	18	1.0k 1.3×	1.2k 1.6×	529 1.0×	195 0.7×	75 0.6×	37	1.5k
Zhenfan Yang China	19	1.2k 1.5×	1.1k 1.5×	549 1.0×	308 1.2×	91 0.8×	39	1.8k
Fabrice Branle Switzerland	15	796 1.0×	951 1.3×	578 1.1×	209 0.8×	85 0.7×	36	1.5k
Graham H.P. Richmond United Kingdom	5	321 0.4×	473 0.6×	492 0.9×	175 0.7×	61 0.5×	6	947
J.L. Breau France	9	468 0.6×	778 1.1×	385 0.7×	207 0.8×	88 0.7×	21	1.2k
Maruja E. Lira United States	21	628 0.8×	610 0.8×	635 1.2×	435 1.6×	79 0.7×	32	1.3k
Jeremy Cetnar United States	14	788 1.0×	905 1.2×	372 0.7×	233 0.9×	62 0.5×	42	1.4k
Teresa Di Desidero Italy	24	253 0.3×	542 0.7×	421 0.8×	200 0.8×	92 0.8×	52	1.1k
Alexios Matikas Sweden	19	370 0.5×	929 1.3×	395 0.7×	413 1.6×	69 0.6×	92	1.4k

Countries citing papers authored by A-P Meert

Since Specialization

Citations

This map shows the geographic impact of A-P Meert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A-P Meert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A-P Meert more than expected).

Fields of papers citing papers by A-P Meert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A-P Meert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A-P Meert. The network helps show where A-P Meert may publish in the future.

Co-authorship network of co-authors of A-P Meert

This figure shows the co-authorship network connecting the top 25 collaborators of A-P Meert. A scholar is included among the top collaborators of A-P Meert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A-P Meert. A-P Meert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Meert, A-P, et al.. (2023). Immune checkpoint inhibitor–induced diabetes mellitus. 44(2). 127–129.

Meert, A-P, et al.. (2022). Post-chemotherapy heat stroke during the hottest week of the year. 43(2). 161–164. 1 indexed citations

Meert, A-P. (2019). Oncological emergencies. Oxford University Press eBooks. 25(8 Pt 2). 631–654.

Grigoriu, Bogdan, et al.. (2014). [Management of extensive disease small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party].. PubMed. 35(3). 164–8. 1 indexed citations

Grève, Jacques De, Johan Vansteenkiste, Erik Teugels, et al.. (2011). FIRST-LINE ERLOTINIB IN PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) CARRYING AN ACTIVATING EGFR MUTATION: A MULTICENTRE ACADEMIC PHASE II STUDY IN BELGIUM. VUBIR (Vrije Universiteit Brussel). 6(6). 1270–1270. 2 indexed citations

Meert, A-P. (2008). [Stage IV NSCLC. Place of chemotherapy].. PubMed. 25(8 Pt 2). 3S107–12. 1 indexed citations

Berchier, M.C., Thierry Berghmans, Benoît Colinet, et al.. (2007). European Lung Cancer Working Party Clinical Practice Guidelines. Small Cell Lung Cnacer: IV. Limited disease. 2(2). 74–82. 1 indexed citations

Jp, Sculier, Thierry Berghmans, & A-P Meert. (2007). [Indications and results of intensive care in patients with lung cancer].. PubMed. 24(8 Pt 2). 6S114–9. 1 indexed citations

Meert, A-P, et al.. (2006). Non-invasive Ventilation in Cancer Patients: a historically matched controlled study. 1(2). 93–98. 1 indexed citations

10.

Mascaux, Céline, Bradley C. Martin, M Paesmans, et al.. (2006). Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results. British Journal of Cancer. 95(2). 139–145. 45 indexed citations

11.

Berghmans, T., A-P Meert, Vincent Ninane, & Sculier Jp. (2005). Mitomycin, ifosfamide, cisplatin for non-small cell lung cancer: an implementation study. Monaldi Archives for Chest Disease. 63(4). 184–92. 1 indexed citations

12.

Mascaux, Céline, N. Iannino, Bradley C. Martin, et al.. (2004). The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis. British Journal of Cancer. 92(1). 131–139. 457 indexed citations

13.

Martin, Bradley C., M Paesmans, Céline Mascaux, et al.. (2004). Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. British Journal of Cancer. 91(12). 2018–2025. 231 indexed citations

14.

Meert, A-P, J‐M Verdebout, Bradley C. Martin, et al.. (2003). Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions. European Respiratory Journal. 21(4). 611–615. 25 indexed citations

15.

Martin, Benoı̂t, M Paesmans, Thierry Berghmans, et al.. (2003). Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis. British Journal of Cancer. 89(1). 55–64. 130 indexed citations

16.

Meert, A-P, M Paesmans, Benjamín Martín, et al.. (2002). The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. British Journal of Cancer. 87(7). 694–701. 193 indexed citations

17.

Meert, A-P, Bradley C. Martin, P. Delmotte, et al.. (2002). The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. European Respiratory Journal. 20(4). 975–981. 230 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact